BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//ACC//Meetings//EN
BEGIN:VTIMEZONE
TZID:Eastern Standard Time
BEGIN:STANDARD
DTSTART:16011101T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:Eastern Standard Time
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:16010301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:Eastern Daylight Time
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:This webinar will focus on medical treatment strategies for obs
tructive HCM\, as part of the Accelerating Innovation for Medical Excellen
ce in Hypertrophic Cardiomyopathy initiative\, and will be moderated by Ma
tthew Martinez\, MD\, FACC. Medical advances in recent years continue to i
mprove HCM care. We aim to discuss how to best approach symptomatic obstru
ctive HCM with optimal medical therapy. We will focus on patient selection
\, optimal dose and potential pitfalls with traditional and novel medical
therapies for obstructive HCM.\nKey Objectives/Learning Outcomes\n\nIdenti
fy the medical management of HCM including a role for CMI therapy.\nIdenti
fy a guideline driven medical approach for treatment of obstructive HCM\nL
ist the emerging medical options for treatment of obstructive HCM\nIdentif
y risks\, benefits\, and pitfalls with emerging medical treatments for obs
tructive HCM.\n\n\n\n\n\n\n\n\n .videoWrapper {\n position: relative
\;\n padding-bottom: 56.25%\; /* 16:9 */\n padding-top: 25px\;\n
height: 0\;\n }\n .videoWrapper iframe {\n position: absolute\;\n
top: 0\;\n left: 0\;\n width: 100%\;\n height: 100%\;\n }\
n
DTEND;TZID=Eastern Standard Time:20221115T124500
DTSTAMP:20260627T173834Z
DTSTART;TZID=Eastern Standard Time:20221115T123000
LOCATION:Online - Eastern Time (ET)
SEQUENCE:0
SUMMARY:HCM Hot Topic Tuesdays: Has the Treatment Strategy Changed?
UID:a2443102-eaab-410a-92dd-f00991308a80@acc.org
X-ALT-DESC;FMTTYPE=text/html:
This webinar will focus o
n medical treatment strategies for obstructive HCM\, as part of the Accele
rating Innovation for Medical Excellence in Hypertrophic Cardiomyopathy in
itiative\, and will be moderated by Matthew Martinez\, MD\, FACC. Medical
advances in recent years continue to improve HCM care. We aim to discuss h
ow to best approach symptomatic obstructive HCM with optimal medical thera
py. We will focus on patient selection\, optimal dose and potential pitfal
ls with traditional and novel medical therapies for obstructive HCM.
\n
Key Objectives/Learning Outcomes\n
\n
Identify t
he medical management of HCM including a role for CMI therapy.
\n
I
dentify a guideline driven medical approach for treatment of obstructive H
CM
\n
List the emerging medical options for treatment of obstructiv
e HCM
\n
Identify risks\, benefits\, and pitfalls with emerging med
ical treatments for obstructive HCM.